| Literature DB >> 35018012 |
Wagisha Barbi1, Kumari Shalini2, Anjali Kumari3, Vaibhava Raaj4, Hitesh Gupta5, Preeti Gauniyal6, Priyadarshini Rangari7.
Abstract
BACKGROUND: Weakened immune system from acquired immunodeficiency syndrome (AIDS) makes the individual prone to various opportunistic infections which are life-threatening including various carcinomas and disorders affecting the neurological system. AIMS: The present trial was done to assess the prevalence of oral presentations and treatment needs in AIDS/human immunodeficiency virus (HIV)-infected subjects visiting antiretroviral therapy centers.Entities:
Keywords: Acquired immunodeficiency syndrome; antiretroviral therapy; candidiasis; dentition status; human immunodeficiency virus; treatment needs
Year: 2021 PMID: 35018012 PMCID: PMC8686892 DOI: 10.4103/jpbs.jpbs_256_21
Source DB: PubMed Journal: J Pharm Bioallied Sci ISSN: 0975-7406
Oral lesions and conditions in HIV patients
| Oral lesion/condition | Females ( | Males ( | Total ( |
|
|---|---|---|---|---|
| Normal | 36.36% (16) | 24.39% (20) | 28.58% (36) | 0.002 |
| Ulceration | 6.81% (3) | 10.97% (9) | 9.52% (12) | 0.10 |
| Leukoplakia | - | 6.09% (5) | 3.96% (5) | 0.001 |
| Lichen planus | - | - | - | - |
| Pigmentation | 11.36 (5) | 17.07% (14) | 15.07% (19) | 0.10 |
| Abscess | 4.54% (2) | 4.87% (4) | 4.76% (6) | 0.9 |
| Bald tongue | 6.81% (3) | 2.43% (2) | 3.96% (5) | 0.02 |
| Angular cheilitis | 4.54% (2) | 6.09% (5) | 5.55% (7) | 0.46 |
| Candidiasis | 31.81% (14) | 32.92% (27) | 32.53% (41) | 0.62 |
| Malignancy | 2.27% (1) | 2.43% (2) | 2.38% (3) | 0.36 |
| ANUG (acute) | 22.72% (10) | 26.82% (22) | 25.39% (32) | 0.28 |
ANUG: Acute necrotizing ulcerative gingivitis
Periodontal status in HIV patients
| Periodontal parameter | Females ( | Males ( | Total ( |
|
|---|---|---|---|---|
| Loss of attachment (mm) | ||||
| 0: 0-3 | 59.09% (26) | 42.68% (35) | 48.41% (61) | 0.001 |
| 1: 4-5 | 29.5% (13) | 28.04% (23) | 28.57% (36) | 0.001 |
| 2: 6-8 | 4.54% (2) | 12.19% (10) | 9.52% (12) | 0.001 |
| 3: 9-11 | 2.27% (1) | 2.43% (2) | 2.38% (3) | 0.001 |
| 4: ≥12 | 0 (0) | 2.43% (2) | 1.58% (2) | 0.001 |
| 9: Not recorded with probe | 2.27% (1) | 10.97% (9) | 7.93% (10) | 0.001 |
| Total | 34.09% (15) | 65.85% (54) | 54.76% (69) | 0.001 |
| Community periodontal index | ||||
| 0-Healthy | 4.54% (2) | 4.87% (4) | 4.76% (6) | 0.001 |
| 1-Bleeding | 54.54% (24) | 48.78% (40) | 50.79% (64) | 0.001 |
| 2-Calculus | 31.81% (14) | 28.04% (23) | 29.36% (37) | 0.001 |
| 3-Pocket (4-5 mm) | 4.54% (2) | 17.07% (14) | 12.69% (16) | 0.001 |
| 4-≥6 mm pocket | 34.09% (15) | 65.85% (54) | 54.76% (69) | 0.001 |
| Total | 59.09% (26) | 42.68% (35) | 48.41% (61) | 0.001 |
Decayed missing and filled teeth and dentition status in human immunodeficiency virus infected study subjects
| Dentition parameter (DMFT) | Mean±SD |
|
|---|---|---|
| Decayed | ||
| Male | 3.38±1263 | 0.001 |
| Female | 2.76±1.012 | |
| Missed | ||
| Male | 0.86±0.676 | 0.001 |
| Female | 0.52±0.503 | |
| Filled | ||
| Male | 0.12±0.431 | 0.69 |
| Female | 0.09±0.374 | |
| Total DMFT | ||
| Male | 4.36±1.601 | 0.001 |
| Female | 3.48±1.243 |
DMFT: Decayed, Missing and Filled Teeth, SD: Standard deviation
Treatment needs in human immunodeficiency virus infected study subjects
| Treatment needed | Females ( | Males ( | Total ( |
|
|---|---|---|---|---|
| No treatment | 2.27% (1) | 2.43% (2) | 2.38% (3) | 0.21 |
| Pit and fissure sealants | 2.27% (1) | 4.87% (4) | 3.96% (5) | 0.01 |
| Single surface restoration | 72.72% (32) | 85.36% (70) | 80.95% (102) | 0.001 |
| Restoration on more than one surface | 63.63% (28) | 59.76% (49) | 61.11% (77) | 0.39 |
| Prosthesis | 72.72% (32) | 68.29% (56) | 69.84% (88) | 0.33 |
| Extraction | 68.18% (30) | 74.39% (61) | 72.22% (91) | 0.3 |
| Pulpal treatment | 47.72% (21) | 40.24% (33) | 42.85% (54) | 0.02 |